Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric D Werner

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|June 17, 2004
Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302Eric D Werner, Jongsoon Lee, Lone Hansen, et al.
The Journal of Biological Chemistry|March 20, 2002
Structure of the globular tail of nuclear laminSirano Dhe-Paganon, Eric D Werner, Young-In Chi, et al.
Nature Structural & Molecular Biology|September 21, 2004
A phenylalanine zipper mediates APS dimerizationSirano Dhe-Paganon, Eric D Werner, Masahiro Nishi, et al.
The Journal of Biological Chemistry|October 19, 2001
Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin actionVincent Aguirre, Eric D Werner, Jodel Giraud, et al.
The Journal of Biological Chemistry|December 21, 2002
Grb10 inhibits insulin-stimulated insulin receptor substrate (IRS)-phosphatidylinositol 3-kinase/Akt signaling pathway by disrupting the association of IRS-1/IRS-2 with the insulin receptorKeriLyn R Wick, Eric D Werner, Paul Langlais, et al.
Molecular and Cellular Biology|March 16, 2005
Kinase activation through dimerization by human SH2-BMasahiro Nishi, Eric D Werner, Byung-Chul Oh, et al.
The Journal of Biological Chemistry|July 9, 2011
Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growthRoselyne Castonguay, Eric D Werner, Robert G Matthews, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2008
A soluble activin type IIA receptor induces bone formation and improves skeletal integrityR Scott Pearsall, Ernesto Canalis, Milton Cornwall-Brady, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 10, 2010
Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivoAndrew D Chantry, Debby Heath, Aaron W Mulivor, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|June 17, 2004
Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302Eric D Werner, Jongsoon Lee, Lone Hansen, et al.
The Journal of Biological Chemistry|March 20, 2002
Structure of the globular tail of nuclear laminSirano Dhe-Paganon, Eric D Werner, Young-In Chi, et al.
Nature Structural & Molecular Biology|September 21, 2004
A phenylalanine zipper mediates APS dimerizationSirano Dhe-Paganon, Eric D Werner, Masahiro Nishi, et al.
The Journal of Biological Chemistry|October 19, 2001
Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin actionVincent Aguirre, Eric D Werner, Jodel Giraud, et al.
The Journal of Biological Chemistry|December 21, 2002
Grb10 inhibits insulin-stimulated insulin receptor substrate (IRS)-phosphatidylinositol 3-kinase/Akt signaling pathway by disrupting the association of IRS-1/IRS-2 with the insulin receptorKeriLyn R Wick, Eric D Werner, Paul Langlais, et al.
Molecular and Cellular Biology|March 16, 2005
Kinase activation through dimerization by human SH2-BMasahiro Nishi, Eric D Werner, Byung-Chul Oh, et al.
The Journal of Biological Chemistry|July 9, 2011
Soluble endoglin specifically binds bone morphogenetic proteins 9 and 10 via its orphan domain, inhibits blood vessel formation, and suppresses tumor growthRoselyne Castonguay, Eric D Werner, Robert G Matthews, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2008
A soluble activin type IIA receptor induces bone formation and improves skeletal integrityR Scott Pearsall, Ernesto Canalis, Milton Cornwall-Brady, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 10, 2010
Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivoAndrew D Chantry, Debby Heath, Aaron W Mulivor, et al.
Pageof 1